2018. Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S3. DOI:https://doi.org/10.25251/skin.2.supp.3.